Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology

Experimental Biology and Medicine

Volumn 242, Issue 16, 2017, Pages 1559-1572

  Watson, David E ^a   Hunziker, Rosemarie ^b   Wikswo, John P ^c  

^a ELI LILLY AND COMPANY   (United States)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

disease models; drug development; engineered organoids; homunculi; Organs on chips; toxicology

Indexed keywords

DIMETICONE; INTERLEUKIN 2;

BIOTECHNOLOGY; ELECTROPHYSIOLOGY; GENE EXPRESSION; HUMAN; IMMUNOLOGY; INDUCED PLURIPOTENT STEM CELL; LUNG EDEMA; MARKETING; MEDICAL RESEARCH; METABOLOMICS; NONHUMAN; NOTE; PATIENT SAFETY; PHENOTYPE; PREDICTIVE VALUE; PRINCIPAL COMPONENT ANALYSIS; PROPHYLAXIS; RISK FACTOR; TOXICOLOGY; DEVICES; LAB ON A CHIP; MICROCHIP ANALYSIS; MICROFLUIDICS; PHYSIOLOGY; PRECLINICAL STUDY; PROCEDURES; TISSUE ENGINEERING;

DRUG EVALUATION, PRECLINICAL; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LAB-ON-A-CHIP DEVICES; MICROCHIP ANALYTICAL PROCEDURES; MICROFLUIDICS; TISSUE ENGINEERING;

EID: 85032345063     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370217732765     Document Type: Note

References (129)

1. Abbott EA., Flatland: a romance of many dimensions. New and revised ed. Oxford: Benediction Classics, 2012
2. Horrobin DF., Modern biomedical research: an internally self-consistent universe with little contact with medical reality? Nat Rev Drug Discov 2003;2:151–4
3. Pedersen JA, Swartz MA., Mechanobiology in the third dimension. Ann Biomed Eng 2005;33:1469–90
4. Albrecht DR, Underhill GH, Wassermann TB, Sah RL, Bhatia SN., Probing the role of multicellular organization in three-dimensional microenvironments. Nat Methods 2006;3:369–75
5. Baker BM, Chen CS., Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues. J Cell Sci 2012;125:3015–24
6. Edmondson R, Broglie JJ, Adcock AF, Yang LJ., Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol 2014;12:207–18
7. Leung BM, Moraes C, Cavnar SP, Luker KE, Luker GD, Takayama S., Microscale 3D collagen cell culture assays in conventional flat-bottom 384-well plates. J Lab Autom 2015;20:138–45
8. Abbott A., Cell culture: biology’s new dimension. Nature 2003;424:870–2
9. Griffith LG, Swartz MA., Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 2006;7:211–24
10. Pampaloni F, Reynaud EG, Stelzer EHK., The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 2007;8:839–45
11. Schmeichel KL, Bissell MJ., Modeling tissue-specific signaling and organ function in three dimensions. J Cell Sci 2003;116:2377–88
12. McMillin DW, Negri JM, Mitsiades CS., The role of tumour-stromal interactions in modifying drug response: challenges and opportunities. Nat Rev Drug Discov 2013;12:217–28
13. Bissell M., Experiments that point to a new understanding of cancer (TED Talk) 2016, https://www.ted.com/talks/mina_bissell_experiments_that_point_to_a_new_understanding_of_cancer (accessed 28 September 2017)
14. Hughes DJ, Kostrzewski T, Sceats EL., Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems. Exp Biol Med 2017;242:1593–604
15. Soto-Gutierrez A, Gough A, Vernetti LA, Taylor DL, Monga SP., Pre-clinical and clinical investigations of metabolic zonation in liver diseases: the potential of microphysiology systems. Exp Biol Med 2017;242:1605–16
16. Lee-Montiel FT, George SM, Gough AH, Sharma AD, Wu J, DeBiasio R, Vernetti LA, Taylor DL., Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systems. Exp Biol Med 2017;242:1617–32
17. Blutt SE, Broughman JR, Zou W, Zeng X-L, Karandikar UC, In J, Zachos NC, Kovbasnjuk O, Donowitz M, Estes MK., Gastrointestinal microphysiological systems. Exp Biol Med 2017;242:1633–42
18. Barry C, Schmitz MT, Propson NE, Hou Z, Zhang J, Nguyen BK, Bolin JM, Jiang P, McIntosh BE, Probasco MD, Swanson S, Stewart R, Thomson JA, Schwartz MP, Murphy WL., Uniform neural tissue models produced on synthetic hydrogels using standard culture techniques. Exp Biol Med 2017;242:1679–89
19. Phan DT, Bender RHF, Andrejecsk JW, Sobrino A, Hachey SJ, George SC, Hughes CC., Blood-brain barrier-on-a-chip: microphysiological systems that capture the complexity of the blood-central nervous system interface. Exp Biol Med 2017;242:1669–78
20. Abaci HE, Guo Z, Doucet Y, Jackow J, Christiano A., Next generation human skin constructs as advanced tools for drug development. Exp Biol Med 2017;242:1657–68
21. Young AN, Moyle-Heyrman G, Kim JJ, Burdette JE., Microphysiologic systems in female reproductive biology. Exp Biol Med 2017;242:1690–1700
22. Powers MJ, Domansky K, Kaazempur-Mofrad MR, Kalezi A, Capitano A, Upadhyaya A, Kurzawski P, Wack KE, Stolz DB, Kamm R, Griffith LG., A microfabricated array bioreactor for perfused 3D liver culture. Biotechnol Bioeng 2002;78:257–69
23. Sin A, Chin KC, Jamil MF, Kostov Y, Rao G, Shuler ML., The design and fabrication of three-chamber microscale cell culture analog devices with integrated dissolved oxygen sensors. Biotechnol Prog 2004;20:338–45
24. Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE., Reconstituting organ-level lung functions on a chip. Science 2010;328:1662–8 (including supporting online material)
25. Huh D, Leslie DC, Matthews BD, Fraser JP, Jurek S, Hamilton GA, Thomeloe KS, McAlexander MA, Ingber DE., A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci Transl Med 2012;4:159ra147
26. Wikswo JP., The relevance and potential roles of microphysiological systems in biology and medicine. Exp Biol Med 2014;239:1061–72
27. Fabre K, Livingston C, Tagle DA., Organs-on-chips (microphysiological systems): tools to expedite efficacy and toxicity testing in human tissue. Exp Biol Med 2014;239:1073–7
28. Slikker W, Jr. Of human-on-a-chip and humans: considerations for creating and using microphysiological systems. Exp Biol Med 2014;239:1078–9
29. Alexander PG, Gottardi R, Lin H, Lozito TP, Tuan RS., Three-dimensional osteogenic and chondrogenic systems to model osteochondral physiology and degenerative joint diseases. Exp Biol Med 2014;239:1080–95
30. Pamies D, Hartung T, Hogberg HT., Biological and medical applications of a brain-on-chip. Exp Biol Med 2014;239:1096–107
31. Hartman KG, Bortner JD, Jr Falk GW, Ginsberg GG, Jhala N, Jian Yu, Martin MG, Rustqi AK, Lynch JP., Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems. Exp Biol Med 2014;239:1108–23
32. Foulke-A J, In J, Kovbasnjuk O, Zachos NC, Ettayebi K, Blutt SE, Hyser JM, Zeng XL, Crawford SE, Broughman JR, Estes MK, Donowitz M., Human enteroids as an ex-vivo model of host-pathogen interactions in the gastrointestinal tract. Exp Biol Med 2014;239:1124–34
33. Nichols JE, Niles JA, Vega SP, Argueta LB, Eastaway A, Cortiella J., Modeling the lung: Design and development of tissue engineered macro- and micro-physiologic lung models for research use. Exp Biol Med 2014;239:1135–69
34. Clark AM, Wheeler SE, Taylor DP, Pillai VC, Young CL, Prantil-Baun R, Nguyen T, Stolz DB, Borenstein JT, Lauffenburger DA, Venkataramanan R, Griffith LG, Wells A. A, microphysiological system model of therapy for liver micrometastases. Exp Biol Med 2014;239:1170–9
35. Bale SS, Vernetti L, Senutovitch N, Jindal R, Hegde M, Gough A, McCarty WJ, Bakan A, Bhushan A, Shun TY, Golberg I, DeBiasio R, Usta BO, Taylor DL, Yarmush ML., In vitro platforms for evaluating liver toxicity. Exp Biol Med 2014;239:1180–91
36. Eddie SL, Kim JJ, Woodruff TK, Burdette JE., Microphysiological modeling of the reproductive tract: a fertile endeavor. Exp Biol Med 2014;239:1192–202
37. Cheng CS, Davis BNJ, Maddan L, Bursac N, Truskey GA., Physiology and metabolism of tissue-engineered skeletal muscle. Exp Biol Med 2014;239:1203–14
38. Eungdamrong NJ, Higgins C, Guo Z, Lee WH, Gillette B, Sia S, Christiano AM., Challenges and promises in modeling dermatologic disorders with bioengineered skin. Exp Biol Med 2014;239:1215–24
39. Sung JH, Srinivasan B, Esch MB, McLamb WT, Bernabini C, Shuler ML, Hickman JJ., Using physiologically-based-pharmacokinetic-guided “body-on-a-chip” systems to predict mammalian response to drug and chemical exposure. Exp Biol Med 2014;239:1225–39
40. Heylman C, Sobrino A, Shirure VS, Hughes CCW, George SC. A, strategy for integrating essential three-dimensional microphysiological systems of human organs for realistic anticancer drug screening. Exp Biol Med 2014;239:1240–54
41. Cimetta E, Vunjak-Novakovic G., Microscale technologies for regulating human stem cell differentiation. Exp Biol Med 2014;239:1255–63
42. Tourovskaia A, Fauver M, Kramer G, Simonson S, Neumann T., Tissue-engineered microenvironment systems modeling human vasculature. Exp Biol Med 2014;239:1264–71
43. Wikswo JP, Porter AP., Biology coming full circle: joining the whole and the parts. Exp Biol Med 2015;240:3–7
44. Zhang B, Radisic M., Organ-on-a-chip devices advance to market. Lab Chip 2017;17:2395–2420
45. Low LA, Tagle DA., Organs-on-chips: progress, challenges, and future directions. Exp Biol Med 2017;242:1573–8
46. Ewart L, Fabre K, Chakilam A, Dragan Y, Duignan D, Eswaraka J, Gan J, Guzzie-Peck P, Otieno M, Jeong CG, Keller DA, de Morais SM, Phillips JA, Proctor W, Sura R, Van Vleet T, Watson D, Will Y, Tagle D, Berridge B., Navigating tissue chips from development to dissemination: a pharmaceutical industry perspective. Exp Biol Med 2017;242:1579–85
47. Knudsen T, Klieforth B, Slikker W., Programming microphysiological systems for children's health protection. Exp Biol Med 2017;242:1586–92
48. Wang YI, Oleaga C, Long CJ, Esch MB, McAleer CW, Miller PG, Hickman JJ, Shuler ML., Self-contained, low-cost body-on-a-chip systems for drug development. Exp Biol Med 2017;242:1701–13
49. Coppeta JR, Mescher MJ, Isenberg BC, Spencer AJ, Kim ES, Lever AR, Mulhern TJ, Prantil-Baun R, Comolli JC, Borenstein JT. A, portable and reconfigurable multi-organ platform for drug development with onboard microfluidic flow control. Lab Chip 2017;17:134–44
50. Xiao S, Coppeta JR, Rogers HB, Isenberg BC, Zhu J, Olalekan SA, McKinnon KE, Dokic D, Rashedi AS, Haisenleder DJ, Malpani SS, Arnold-Murray CA, Chen K, Jiang M, Bai L, Nguyen CT, Zhang J, Laronda MM, Hope TJ, Maniar KP, Pavone ME, Avram MJ, Sefton EC, Getsios S, Burdette JE, Kim JJ, Borenstein JT, Woodruff TK., A microfluidic culture model of the human reproductive tract and 28–day menstrual cycle. Nat Commun 2017;8:14584
51. Cyr KJ, Avaldi OM, Wikswo JP., Circadian hormone control in a human-on-a-chip: In vitro biology’s ignored component? Exp Biol Med 2017;242:1714–31
52. Wikswo JP, Block FE, III Cliffel DE, Goodwin CR, Marasco CC, Markov DA, McLean DL, McLean JA, McKenzie JR, Reiserer RS, Samson PC, Schaffer DK, Seale KT, Sherrod SD., Engineering challenges for instrumenting and controlling integrated organ-on-chip systems. IEEE Trans Biomed Eng 2013;60:682–90
53. Sung JH, Kam C, Shuler ML., A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip. Lab Chip 2010;10:446–55
54. Lee H, Kim DS, Ha SG, Choi I, Lee JM, Sung JH. A, pumpless multi-organ-on-a-chip (MOC) combined with a pharmacokinetic-pharmacodynamic (PK-PD) model. Biotechnol Bioeng 2016;114:432–43
55. Wagner I, Materne EM, Brincker S, Sussbier U, Fradrich C, Busek M, Sonntag F, Sakharov DA, Trushkin EV, Tonevitsky AG, Lauster R, Marx U. A, dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture. Lab Chip 2013;13:3538–47
56. Maschmeyer I, Lorenz AK, Schimek K, Hasenberg T, Ramme AP, Hübner J, Lindner M, Drewell C, Bauer S, Thomas A, Sambo NS, Sonntag F, Lauster R, Marx U. A, four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip 2015;15:2688–99
57. Zhang C, Zhao ZQ, Rahim NAA, van Noort D, Yu H., Towards a human-on-chip: culturing multiple cell types on a chip with compartmentalized microenvironments. Lab Chip 2009;9:3185–92
58. Esch MB, Smith AST, Prot JM, Oleaga C, Hickman JJ, Shuler ML., How multi-organ microdevices can help foster drug development. Adv Drug Del Rev 2014;69:158–69
59. Borysiak MD, Bielawski KS, Sniadecki NJ, Jenkel CF, Vogt BD, Posner JD., Simple replica micromolding of biocompatible styrenic elastomers. Lab Chip 2013;13:2773–84
60. Borysiak MD, Yuferova E, Posner JD., Simple, low-cost styrene-ethylene/butylene-styrene microdevices for electrokinetic applications. Anal Chem 2013;85:11700–4
61. Wasay A, Sameoto D., Gecko gaskets for self-sealing and high-strength reversible bonding of microfluidics. Lab Chip 2015;15:2749–53
62. Fernandez-Alcon J, Wen N, Novak R, Ingber DE, Hamilton GA, Hinojosa C, Domanasky K, Levner D, Thompson G, Hajipouran Benam K, Villenave R, Umundum T, Paris A, Bauer G, inventors; President and fellows of Harvard College (Cambridge, MA, US), assignee. Organomimetic devices and methods of use and manufacturing thereof. Patent application 20160326477, USA, 2016.
63. Domansky K, Sliz JD, Wen N, Hinojosa C, Thompson G, Fraser JP, Hamkins-Indik T, Hamilton GA, Levner D, Ingber DE. SEBS, elastomers for fabrication of microfluidic devices with reduced drug absorption by injection molding and extrusion. Microfluid Nanofluid 2017;21:107
64. Kilic O, Pamies D, Lavell E, Schiapparelli P, Feng Y, Hartung T, Bal-Price A, Hogberg HT, Quinones-Hinojosa A, Guerrero-Cazares H, Levchenko A., Brain-on-a-chip model enables analysis of human neuronal differentiation and chemotaxis. Lab Chip 2016;16:4152–62
65. Sip CG, Bhattacharjee N, Folch A., Microfluidic transwell inserts for generation of tissue culture-friendly gradients in well plates. Lab Chip 2014;14:302–14
66. Karolak A, Huffstutler B, Markov DA, McCawley LJ, Rejniak KA., Elucidating the role of tumor microenvironmental heterogeneity with a computational model of 3D breast spheroids. Biophys J 2017;112:45a
67. Kim HJ, Huh D, Hamilton G, Ingber DE., Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 2012;12:2165–74
68. Senutovitch N, Vernetti L, Boltz R, DeBiasio R, Gough A, Taylor DL., Fluorescent protein biosensors applied to microphysiological systems. Exp Biol Med 2015;240:795–808
69. Lind JU, Busbee TA, Valentine AD, Pasqualini FS, Yuan HY, Yadid M, Park SJ, Kotikian A, Nesmith AP, Campbell PH, Vlassak JJ, Lewis JA, Parker KK., Instrumented cardiac microphysiological devices via multimaterial three-dimensional printing. Nat Mater 2017;16:303–8
70. Parker KK, Feinberg AW, Whitesides GM, Shevkoplyas SS, Feigel A, inventors; President and fellows of Harvard College (Cambridge, MA, US), assignee. Engineered cell growth on polymeric films and biotechnological applications thereof. US Patent 9,383,350 B2, 2016
71. Mathur A, Loskill P, Shao KF, Huebsch N, Hong S, Marcus SG, Marks N, Mandegar M, Conklin BR, Lee LP, Healy KE., Human iPSC-based cardiac microphysiological system for drug screening applications. Sci Rep 2015;5:Article 8883
72. Huebsch N, Loskill P, Mandegar MA, Marks NC, Sheehan AS, Ma Z, Mathur A, Nguyen TN, Yoo JC, Judge LM, Spencer CI, Chukka AC, Russell CR, So P-L, Conklin BR, Healy KE., Automated video-based analysis of contractility and calcium flux in human-induced pluripotent stem cell-derived cardiomyocytes cultured over different spatial scales. Tissue Eng Part C Methods 2015;21:467–79
73. Sidorov VY, Samson PC, Sidorova TN, Davidson JM, Lim CC, Wikswo JP., I-Wire heart-on-a-chip I: three-dimensional cardiac tissue constructs for physiology and pharmacology. Acta Biomater 2017;48:68–78
74. Schroer AK, Shotwell MS, Sidorov VY, Wikswo JP, Merryman WD., I-Wire heart-on-a-chip II: biomechanical analysis of contractile, three-dimensional cardiomyocyte tissue constructs. Acta Biomater 2016;48:79–87
75. Ma SP, Vunjak-Novakovic G., Tissue-engineering for the study of cardiac biomechanics. J Biomech Eng Trans ASME 2016;138:021010
76. Oleaga C, Bernabini C, Smith AST, Srinivasan B, Jackson M, McLamb W, Platt V, Bridges R, Cai Y, Santhanam N, Berry B, Najjar S, Akanda N, Guo X, Martin C, Ekman G, Esch MB, Langer J, Ouedraogo G, Cotovio J, Breton L, Shuler ML, Hickman JJ., Multi-organ toxicity demonstration in a functional human in vitro system composed of four organs. Sci Rep 2016;6:20030
77. Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML, Hickman JJ., TEER measurement techniques for in vitro barrier model systems. J Lab Autom 2015;20:107–26
78. Brown JA, Codreanu SG, Shi M, Sherrod SD, Markov DA, Neely MD, Britt CM, Hoilett OS, Reiserer RS, Samson PC, McCawley LJ, Webb DJ, Bowman AB, McLean JA, Wikswo JP., Metabolic consequences of inflammatory disruption of the blood-brain barrier in an organ-on-chip model of the human neurovascular unit. J Neuroinflammation 2016;13:306
79. Brown JA, Pensabene V, Markov DA, Allwardt V, Neely MD, Shi M, Britt CM, Hoilett OS, Yang Q, Brewer BM, Samson PC, McCawley LJ, May JM, Webb DJ, Li D, Bowman AB, Reiserer RS, Wikswo JP., Recreating blood-brain barrier physiology and structure on chip: a novel neurovascular microfluidic bioreactor. Biomicrofluidics 2015;9:Article 054124
80. Odijk M, van der Meer AD, Levner D, Kim HJ, van der Helm MW, Segerink LI, Frimat JP, Hamilton GA, Ingber DE, van den Berg A., Measuring direct current trans-epithelial electrical resistance in organ-on-a-chip microsystems. Lab Chip 2015;15:745–52
81. Helms HC, Abbott NJ, Burek M, Cecchelli R, Couraud PO, Deli MA, Förster C, Galla HJ, Romero IA, Shusta EV, Stebbins MJ, Vandenhaute E, Weksler B, Brodin B., In vitro models of the blood-brain barrier: an overview of commonly used brain endothelial cell culture models and guidelines for their use. J Cereb Blood Flow Metab 2016;36:862–90
82. Stanimirovic DB, Bani-Yaghoub M, Perkins M, Haqqani AS., Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics. Expert Opin Drug Discov 2015;10:141–55
83. Sheehy SP, Grosberg A, Qin P, Behm DJ, Ferrier JP, Eagleson MA, Nesmith AP, Krull D, Falls JG, Campbell PH, McCain ML, Willette RN, Hu E, Parker KK., Toward improved myocardial maturity in an organ-on-chip platform with immature cardiac myocytes. Exp Biol Med 2017;242:1643–56
84. Sutherland JJ, Jolly RA, Goldstein KM, Stevens JL., Assessing concordance of drug-induced transcriptional response in rodent liver and cultured hepatocytes. PLoS Comput Biol 2016;12:e1004847
85. Wang XS, Pandey AK, Mulligan MK, Williams EG, Mozhui K, Li ZS, Jovaisaite V, Quarles LD, Xiao Z, Huang J, Capra JA, Chen Z, Taylor WL, Bastarache L, Niu X, Pollard KS, Ciobanu DC, Reznik AO, Tishkov AV, Zhulin IB, Peng J, Nelson SF, Denny JC, Auwerx J, Lu L, Williams RW., Joint mouse-human phenome-wide association to test gene function and disease risk. Nat Commun 2016;7:10464
86. Norris JL, Farrow MA, Gutierrez DB, Palmer LD, Muszynski N, Sherrod SD, Pino JC, Allen JL, Spraggins JM, Lubbock AL, Jordan A, Burns W, Poland JC, Romer C, Manier ML, Nei YW, Prentice BM, Rose KL, Hill S, Van de Plas R, Tsui T, Braman NM, Keller MR, Rutherford SA, Lobdell N, Lopez CF, Lacy DB, McLean JA, Wikswo JP, Skaar EP, Caprioli RM., An integrated, high-throughput, multi-omics platform enables data-driven construction of cellular responses and reveals global drug mechanisms of action. J Proteome Res 2017;16:1364–75
87. Poulin P, Theil FP., A priori prediction of tissue: plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. J Pharm Sci 2000;89:16–35
88. Price PS, Conolly RB, Chaisson CF, Gross EA, Young JS, Mathis ET, Tedder DR., Modeling interindividual variation in physiological factors used in PBPK models of humans. Crit Rev Toxicol 2003;33:469–503
89. Rodgers T, Leahy D, Rowland M., Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. J Pharm Sci 2005;94:1259–76
90. Jones HM, Rowland-Yeo K., Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development. CPT Pharmacometrics Syst Pharmacol 2013;2:1–12
91. Lu J, Goldsmith M-R, Grulke CM, Chang DT, Brooks RD, Leonard JA, Phillips MB, Hypes ED, Fair MJ, Tornero-Velez R, Johnson J, Dary CC, Tan YM., Developing a physiologically-based pharmacokinetic model knowledgebase in support of provisional model construction. PLoS Comput Biol 2016;12:e1004495
92. Quick DJ, Shuler ML., Use of in vitro data for construction of a physiologically based pharmacokinetic model for naphthalene in rats and mice to probe species differences. Biotechnol Prog 1999;15:540–55
93. Ghanem A, Shuler ML., Combining cell culture analogue reactor designs and PBPK models to probe mechanisms of naphthalene toxicity. Biotechnol Prog 2000;16:334–45
94. Sung JH, Dhiman A, Shuler ML., A combined pharmacokinetic-pharmacodynamic (PK-PD) model for tumor growth in the rat with UFT administration. J Pharm Sci 2009;98:1885–904
95. Sung JH, Esch MB, Shuler ML., Integration of in silico and in vitro platforms for pharmacokinetic-pharmacodynamic modeling. Expert Opin Drug Metab Toxicol 2010;6:1063–81
96. Sung JH, Shuler ML., In vitro microscale systems for systematic drug toxicity study. Bioprocess Biosystems Eng 2010;33:5–19
97. Long TJ, Cosgrove PA, Dunn RT, ll Stolz DB, Hamadeh HK, Afshari C, McBride H, Griffith LG., Modeling therapeutic antibody-small molecule drug-drug interactions using a 3D perfusable human liver co-culture platform. Drug Metab Disposition 2016;44:1940–8
98. Yu J, Cilfone NA, Large EM, Sarkar U, Wishnok JS, Tannenbaum SR, Hughes DJ, Lauffenburger DA, Griffith LG, Stokes CL, Cirit M., Quantitative systems pharmacology approaches applied to microphysiological systems (MPS): data interpretation and multi-MPS integration. CPT Pharmacometrics Syst Pharmacol 2015;4:585–94
99. Abaci HE, Shuler ML., Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling. Integr Biol 2015;7:383–91
100. Shah DK, Betts AM., Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human. J Pharmacokinet Pharmacodyn 2012;39:67–86
101. Rostami-Hodjegan A., Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology. Clin Pharmacol Ther 2012;92:50–61
102. Leung HW., Physiologically based pharmacokinetic modelling. In: Casciano DA, Sahu SC, Ballantyne B, Marrs T, and Syversen T (eds) General, applied and systems toxicology, John Wiley & Sons, Ltd, 2009. DOI: 10.1002/9780470744307.gat008
103. Bois FY., Analysis of PBPK models for risk characterization. Ann NY Acad Sci 1999;895:317–37
104. Clewell HJ III., The application of physiologically based pharmacokinetic modeling in human health risk assessment of hazardous substances. Toxicol Lett 1995;79:207–17
105. Ramadan Q, Gijs MAM., In vitro micro-physiological models for translational immunology. Lab Chip 2015;15:614–36
106. Kim J, Lee H, Selimovic S, Gauvin R, Bae H., Organ-on-a-chip: development and clinical prospects toward toxicity assessment with an emphasis on bone marrow. Drug Saf 2015;38:409–18
107. Higbee RG, Byers AM, Dhir V, Drake D, Fahlenkamp HG, Gangur J, Kachurin A, Kachurina O, Leistritz D, Ma Y, Mehta R, Mishkin E, Moser J, Mosquera L, Nguyen M, Parkhill R, Pawar S, Poisson L, Sanchez-Schmitz G, Schanen B, Singh I, Song H, Tapia T, Warren W, Wittman V., An immunologic model for rapid vaccine assessment – a clinical trial in a test tube. ATLA 2009;37:19–27
108. Ross AE, Belanger MC, Woodroof JF, Pompano RR., Spatially resolved microfluidic stimulation of lymphoid tissue ex vivo. Analyst 2017;142:649–59
109. Passeraub PA, Almeida AC, Thakor NV., Design, microfabrication and analysis of a microfluidic chamber for the perfusion of brain tissue slices. Biomed Microdevices 2003;5:147–55
110. Shaikh Mohammed J, Caicedo H, Fall CP, Eddington DT., Brain slice stimulation using a microfluidic network and standard perfusion chamber. J Vis Exp 2007;8:e302
111. Mohammed JS, Caicedo HH, Fall CP, Eddington DT., Microfluidic add-on for standard electrophysiology chambers. Lab Chip 2008;8:1048–55
112. Queval A, Perrault CM, Qasaimeh MA, McKinney RA, Juncker D., Design and fabrication of a PDMS microfluidic probe and perfusion chamber for microfluidic experiments with organotypic brain slices. In: Locascio LE (ed) Micro total analysis systems 2008: proceedings of the µTAS 2008: twelfth international conference on miniaturized systems for chemistry and life sciences. San Diego, CA: Chemical and Biological Microsystems Society, 2008, pp.166300–5
113. Rambani K, Vukasinovic J, Glezer A, Potter SM., Culturing thick brain slices: an interstitial 3D microperfusion system for enhanced viability. J Neurosci Methods 2009;180:243–54
114. Blake AJ, Rodgers FC, Bassuener A, Hippensteel JA, Pearce TM, Pearce TR, Zarnowska ED, Pearce RA, Williams JC., A microfluidic brain slice perfusion chamber for multisite recording using penetrating electrodes. J Neurosci Methods 2010;189:5–13
115. Queval A, Ghattamaneni NR, Perrault CM, Gill R, Mirzaei M, McKinney RA, Juncker D., Chamber and microfluidic probe for microperfusion of organotypic brain slices. Lab Chip 2010;10:326–34
116. Huang Y, Williams JC, Johnson SM., Brain slice on a chip: opportunities and challenges of applying microfluidic technology to intact tissues. Lab Chip 2012;12:2103–17
117. Mauleon G, Fall CP, Eddington DT., Precise spatial and temporal control of oxygen within in vitro brain slices via microfluidic gas channels. PLoS One 2012;7:e43309
118. van Midwoud PM, Merema MT, Verpoorte E, Groothuis GM. A, microfluidic approach for in vitro assessment of interorgan interactions in drug metabolism using intestinal and liver slices. Lab Chip 2010;10:2778–86
119. Venero Galanternik M, Stratman AN, Jung HM, Butler MG, Weinstein BM., Building the drains: the lymphatic vasculature in health and disease. WIREs Dev Biol 2016;5:689–710
120. Giese C, Marx U., Human immunity in vitro – solving immunogenicity and more. Adv Drug Del Rev 2014;69:103–22
121. Choo SY., The HLA System: Genetics, immunology, clinical testing, and clinical implications. Yonsei Med J 2007;48:11–23
122. Ramadan Q, Jafarpoorchekab H, Huang CB, Silacci P, Carrara S, Koklü G, Ghaye J, Ramsden J, Ruffert C, Vergeres G, Gijs MA., NutriChip: nutrition analysis meets microfluidics. Lab Chip 2013;13:196–203
123. Mills M, Estes MK., Physiologically relevant human tissue models for infectious diseases. Drug Discov Today 2016;21:1540–52
124. Workman MJ, Mahe MM, Trisno S, Poling HM, Watson CL, Sundaram N, Chang CF, Schiesser J, Aubert P, Stanley EG, Elefanty AG, Miyaoka Y, Mandegar MA, Conklin BR, Neunlist M, Brugmann SA, Helmrath MA, Wells JM., Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system. Nat Med 2017;23:49–59
125. Kang JH, Super M, Yung CW, Cooper RM, Domansky K, Graveline AR, Mammoto T, Berthet JB, Tobin H, Cartwright MJ, Watters AL, Rottman M, Waterhouse A, Mammoto A, Gamini N, Rodas MJ, Kole A, Jiang A, Valentin TM, Diaz A, Takahashi K, Ingber DE., An extracorporeal blood-cleansing device for sepsis therapy. Nat Med 2014;20:1211–6
126. Torisawa YS, Spina CS, Mammoto T, Mammoto A, Weaver JC, Tat T, Collins JJ, Ingber DE., Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro. Nat Methods 2014;11:663–9
127. Collins FS, Varmus H. A, new initiative on precision medicine. N Engl J Med 2015;372:793–5
128. Wang G, McCain ML, Yang L, He A, Pasqualini FS, Agarwal A, Yuan H, Jiang D, Zhang D, Zangi L, Geva J, Roberts AE, Ma Q, Ding J, Chen J, Wang DZ, Li K, Wang J, Wanders RJ, Kulik W, Vaz FM, Laflamme MA, Murry CE, Chien KR, Kelley R, Church GM, Parker KK, Pu WT., Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat Med 2014;20:616–23
129. Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, Lilly P, Sanders J, Sipes G, Bracken W, Dorato M, Van Deun K, Smith P, Berger B, Heller A., Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol 2000;32:56–67